VISIONGATE, INC.

Capabilities

The foundation for our diagnostics capability is our proprietary Cell-CT™ 3-Dimensional Cell Imaging and Analysis platform that we believe will transform the ability to image and detect abnormal cells. The Cell-CT platform, using a process called optical computed tomography (Optical CT), produces isometric, sub-micron resolution 3D images of individual cells with the ability to morphologically recognize over 700 structural biomarkers of normal and abnormal cells. VisionGate is developing the Cell-CT platform to improve its ability to identify biosignatures that would classify cells to aid in abnormal cell detection and prediction of disease. The Cell-CT platform can process any liquid biopsy specimen. As such, it has the potential to detect a wide range of different cancers and cancer biosignatures. This could aid in identifying potential treatments using targeted pharmaceutical therapies.